Found 5 matching trials
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM
NATo test the effectiveness and safety of Optune® given concomitantly with ra...
Location
Grandview Cancer Center
Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
NAThe purpose of the study is to assess timing of TTFields use as well as saf...
Location
University Hospital of Heidelberg, Radiation Oncology
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PHASE2This study consists of 2 portions. The phase 2 portion is an open-label, si...
Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
PHASE2This phase II trial will investigate the efficacy and safety of the additio...
Location
University of California, San Diego
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
PHASE3This is a multicenter, two-arm, randomized, double-blind, placebo-controlle...
Location
Mayo Clinic Hospital